Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

Technology appraisal guidance
Reference number: TA209
Published: 24 November 2010

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to consultee, commentator and public comments on the ACD and comments from website consultation

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to consultee, commentator and public comments on the ACD and comments from website consultation

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to consultee, commentator and public comments on the ACD and comments from website consultation
16 September 2010
(152.23 Kb 44 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 13 September 2010